Lauri Markkanen

#23 PF

Utah Jazz

Status

GTD - Shoulder - Pinched Nerve Expected Return: 2024-10-01

Previous game (vs. SAS 3/27)

PTS

REB

AST

BLK

STL

Latest Lauri Markkanen news

Marrkanen (shoulder) signed a five-year, $238 million contract extension with the Jazz on Wednesday, ESPN's Adrian Wojnarowski reports. Markkanen renegotiated his 2024-25 salary as well, earning himself another $24 million. With this extension, Markkanen will not be eligible to be moved prior to the Feb. 6 trade deadline, so it's the forward may be in this for the long haul with Utah. Markkanen will be a very popular target early on in fantasy drafts after averaging 23.2 points, 8.2 rebounds, 2.0 assists and 3.2 three-pointers during the 2023-24 regular season.

2023-24 Season Stats

PTS

REB

AST

BLK

STL

23.2

8.2

2.0

0.5

0.9

1.4

Career Averages

PTS

REB

AST

BLK

STL

18.1

7.3

1.5

0.5

0.7

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2023-24	55	55	33.1	23.2	8.2	2.0	0.5	0.9	1.4	19	3.2	8.0	39.9%	4.6	8.2	55.9%	7.8	16.2	48.0%	4.5	5.0	89.9%	2.2	5.9	1.8	1.4	+21	63.1%
2022-23	66	66	34.4	25.6	8.6	1.9	0.6	0.6	1.9	28	3.0	7.7	39.1%	5.6	9.6	58.5%	8.7	17.3	49.9%	5.3	6.0	87.5%	2.0	6.7	2.1	1.0	+163	64.0%
2021-22	61	61	30.8	14.8	5.7	1.3	0.5	0.7	0.9	3	2.2	6.2	35.8%	2.9	5.3	54.8%	5.1	11.5	44.5%	2.3	2.6	86.8%	1.0	4.7	2.1	1.5	+172	58.2%
2020-21	51	26	25.8	13.6	5.3	0.9	0.3	0.5	1.0	2	2.3	5.8	40.2%	2.6	4.4	58.2%	4.9	10.2	48.0%	1.5	1.8	82.6%	0.7	4.6	1.5	0.9	-48	61.9%
2019-20	50	50	29.8	14.7	6.3	1.5	0.5	0.8	1.6	3	2.2	6.3	34.4%	2.8	5.5	51.8%	5.0	11.8	42.5%	2.5	3.1	82.4%	1.2	5.1	1.9	0.9	-68	56.0%
2018-19	52	51	32.3	18.7	9.0	1.4	0.6	0.7	1.6	20	2.3	6.4	36.1%	4.3	8.9	47.9%	6.6	15.3	43.0%	3.3	3.8	87.2%	1.4	7.6	2.3	0.9	-197	55.3%
2017-18	68	68	29.7	15.2	7.5	1.2	0.6	0.6	1.2	14	2.1	5.9	36.2%	3.4	6.8	49.7%	5.5	12.7	43.4%	2.1	2.4	84.3%	1.2	6.3	1.5	1.0	-387	55.2%
Career	403	377	31.0	18.1	7.3	1.5	0.5	0.7	1.4	89	2.5	6.6	37.5%	3.8	7.0	53.8%	6.3	13.7	45.9%	3.1	3.6	86.6%	1.4	5.9	1.9	1.1	-344	59.5%


Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/16	NZB	W 114-94	17	15	7	0	0	1	0	3	1	33.3%	9	4	44.4%	12	5	41.7%	5	4	80.0%	3	4	0.0	+10	1	18	52.8%
10/14	POR	W 138-133	25	26	9	1	1	0	1	2	2	100.0%	10	7	70.0%	12	9	75.0%	6	6	100.0%	3	6	1.0	+14	2	33	88.8%
10/10	LAC	L 103-98	23	16	8	0	1	1	1	5	1	20.0%	7	5	71.4%	12	6	50.0%	3	3	100.0%	1	7	0.0	-16	2	19	60.1%
10/8	LAC	W 101-96	18	10	8	2	0	0	3	3	0	0.0%	7	4	57.1%	10	4	40.0%	2	2	100.0%	4	4	0.7	-4	0	11	46.0%
Preseason Totals			20.9	16.8	8.0	0.8	0.5	0.5	1.3	3.3	1.0	30.8%	8.3	5.0	60.6%	11.5	6.0	52.2%	4.0	3.8	93.8%	2.8	5.3	0.6	+4	1.3	22.8	63.2%


Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
3/27	SAS	L 118-111	42	25	6	2	0	1	3	7	3	42.9%	10	5	50.0%	17	8	47.1%	6	6	100.0%	1	5	0.7	-3	1	23	63.6%
3/25	DAL	L 115-105	33	34	7	2	1	1	1	9	6	66.7%	10	4	40.0%	19	10	52.6%	8	8	100.0%	3	4	2.0	-2	2	39	75.5%
3/21	DAL	L 113-97	35	21	3	2	0	2	0	9	1	11.1%	11	5	45.5%	20	6	30.0%	8	8	100.0%	0	3	0.0	-19	1	19	44.6%
3/18	MIN	L 114-104	30	22	12	1	1	2	6	5	1	20.0%	11	7	63.6%	16	8	50.0%	5	5	100.0%	3	9	0.2	-7	1	29	60.4%
3/2	MIA	L 126-120	40	25	4	6	1	2	1	9	4	44.4%	6	1	16.7%	15	5	33.3%	12	11	91.7%	2	2	6.0	+6	4	31	61.6%
2/29	ORL	L 115-107	33	18	3	0	0	1	1	7	4	57.1%	8	2	25.0%	15	6	40.0%	2	2	100.0%	2	1	0.0	+0	2	12	56.7%
2/27	ATL	L 124-97	26	11	4	0	0	0	2	6	0	0.0%	7	4	57.1%	13	4	30.8%	4	3	75.0%	2	2	0.0	-23	0	4	37.3%
2/25	SAS	W 128-109	32	26	7	4	1	2	1	8	5	62.5%	10	5	50.0%	18	10	55.6%	1	1	100.0%	1	6	4.0	+9	0	30	70.5%
2/22	CHA	L 115-107	36	21	9	6	0	0	2	9	2	22.2%	5	3	60.0%	14	5	35.7%	10	9	90.0%	1	8	3.0	-11	2	27	57.1%
2/15	GSW	L 140-137	33	20	14	3	0	0	1	11	4	36.4%	12	2	16.7%	23	6	26.1%	4	4	100.0%	5	9	3.0	+8	1	19	40.4%
2/14	LAL	L 138-122	33	16	8	1	1	0	2	7	2	28.6%	8	4	50.0%	15	6	40.0%	2	2	100.0%	2	6	0.5	-16	1	15	50.4%
2/12	GSW	L 129-107	33	19	5	0	0	1	1	7	3	42.9%	10	5	50.0%	17	8	47.1%	0	0	0.0%	0	5	0.0	-26	1	16	55.9%
2/8	PHX	L 129-115	33	22	5	1	0	0	4	6	2	33.3%	9	6	66.7%	15	8	53.3%	4	4	100.0%	0	5	0.3	-8	1	18	65.6%
2/6	OKC	W 124-117	36	33	11	2	0	1	2	7	5	71.4%	11	7	63.6%	18	12	66.7%	4	4	100.0%	3	8	1.0	+15	3	38	83.5%
2/4	MIL	W 123-108	35	21	3	2	0	1	2	10	5	50.0%	5	3	60.0%	15	8	53.3%	0	0	0.0%	1	2	1.0	+20	4	16	70.0%
2/1	PHI	L 127-124	33	28	10	3	0	1	0	9	4	44.4%	6	6	100.0%	15	10	66.7%	4	4	100.0%	2	8	0.0	+1	2	40	83.5%
1/30	NYK	L 118-103	33	14	5	1	0	1	0	8	2	25.0%	6	3	50.0%	14	5	35.7%	2	2	100.0%	2	3	0.0	-10	1	12	47.0%
1/29	BKN	L 147-114	26	13	9	2	0	0	3	4	1	25.0%	8	3	37.5%	12	4	33.3%	4	4	100.0%	4	5	0.7	-19	2	15	47.2%
1/27	CHA	W 134-122	35	33	12	3	0	1	2	12	7	58.3%	6	5	83.3%	18	12	66.7%	2	2	100.0%	3	9	1.5	+19	5	39	87.4%
1/25	WAS	W 123-108	32	29	7	5	0	3	3	12	6	50.0%	8	5	62.5%	20	11	55.0%	2	1	50.0%	1	6	1.7	+11	3	27	69.4%
1/23	NOP	L 153-124	27	11	4	1	0	0	1	5	1	20.0%	10	3	30.0%	15	4	26.7%	2	2	100.0%	2	2	1.0	-14	0	7	34.6%
1/20	HOU	L 127-126	38	22	9	1	0	0	3	11	3	27.3%	7	5	71.4%	18	8	44.4%	4	3	75.0%	3	6	0.3	+8	2	19	55.7%
1/18	OKC	L 134-129	35	26	10	4	0	1	1	4	2	50.0%	9	5	55.6%	13	7	53.8%	11	10	90.9%	1	9	4.0	+0	0	37	72.9%
1/15	IND	W 132-105	28	32	10	3	0	0	1	4	2	50.0%	11	8	72.7%	15	10	66.7%	10	10	100.0%	2	8	3.0	+25	1	45	82.5%
1/13	LAL	W 132-125	33	29	9	5	1	2	0	6	3	50.0%	10	5	50.0%	16	8	50.0%	11	10	90.9%	2	7	0.0	+16	0	40	69.6%
1/12	TOR	W 145-113	29	22	9	2	0	1	3	6	4	66.7%	5	3	60.0%	11	7	63.6%	5	4	80.0%	3	6	0.7	+19	2	27	83.3%
1/10	DEN	W 124-111	32	26	12	2	1	0	0	5	2	40.0%	8	4	50.0%	13	6	46.2%	12	12	100.0%	2	10	0.0	+17	2	39	71.1%
1/8	MIL	W 132-116	31	21	14	2	2	1	0	10	4	40.0%	5	1	20.0%	15	5	33.3%	8	7	87.5%	4	10	0.0	+8	1	36	56.7%
1/6	PHI	W 120-109	34	33	13	1	1	0	1	9	5	55.6%	10	7	70.0%	19	12	63.2%	5	4	80.0%	4	9	1.0	+8	2	40	77.8%
1/5	BOS	L 126-97	23	17	5	5	0	0	0	7	2	28.6%	9	5	55.6%	16	7	43.8%	2	1	50.0%	4	1	0.0	-14	1	16	50.4%
1/3	DET	W 154-148	37	31	7	0	1	0	1	8	4	50.0%	10	6	60.0%	18	10	55.6%	8	7	87.5%	2	5	0.0	+12	1	34	72.0%
1/1	DAL	W 127-90	24	17	4	1	1	1	1	8	4	50.0%	4	2	50.0%	12	6	50.0%	1	1	100.0%	2	2	1.0	+8	0	17	68.3%
12/30	MIA	W 117-109	26	12	5	1	0	2	0	8	1	12.5%	5	3	60.0%	13	4	30.8%	4	3	75.0%	2	3	0.0	+1	4	10	40.7%
12/28	NOP	L 112-105	34	24	10	5	0	1	2	12	3	25.0%	7	4	57.1%	19	7	36.8%	7	7	100.0%	6	4	2.5	+2	0	33	54.3%
12/26	SAS	W 130-118	30	31	12	2	0	1	1	9	5	55.6%	8	7	87.5%	17	12	70.6%	2	2	100.0%	3	9	2.0	+20	3	40	86.7%
12/23	TOR	W 126-119	38	30	9	5	0	3	1	10	4	40.0%	11	8	72.7%	21	12	57.1%	2	2	100.0%	2	7	5.0	+9	2	38	68.6%
12/20	CLE	L 124-116	35	26	10	1	0	0	0	9	3	33.3%	9	5	55.6%	18	8	44.4%	8	7	87.5%	2	8	0.0	-7	3	29	60.4%
12/18	BKN	W 125-108	28	20	10	4	1	0	2	5	1	20.0%	9	5	55.6%	14	6	42.9%	7	7	100.0%	1	9	2.0	+15	1	28	58.5%
12/16	SAC	L 125-104	27	18	6	3	0	0	2	5	2	40.0%	8	5	62.5%	13	7	53.8%	2	2	100.0%	1	5	1.5	-2	2	21	64.8%
12/13	NYK	W 117-113	24	23	7	0	0	0	0	8	4	50.0%	5	3	60.0%	13	7	53.8%	7	5	71.4%	0	7	0.0	-14	2	24	71.5%
11/22	POR	L 121-105	33	24	8	0	0	3	2	6	1	16.7%	12	8	66.7%	18	9	50.0%	6	5	83.3%	3	5	0.0	-1	2	23	58.1%
11/21	LAL	L 131-99	22	10	8	0	0	1	0	7	2	28.6%	3	2	66.7%	10	4	40.0%	0	0	0.0%	1	7	0.0	-9	2	11	50.0%
11/19	PHX	L 140-137	49	38	17	0	2	2	1	10	2	20.0%	17	13	76.5%	27	15	55.6%	9	6	66.7%	7	10	0.0	+2	3	46	61.4%
11/17	PHX	L 131-128	40	21	2	0	2	1	0	4	1	25.0%	8	4	50.0%	12	5	41.7%	12	10	83.3%	0	2	0.0	+1	1	20	60.8%
11/14	POR	W 115-99	31	21	9	0	1	1	0	9	2	22.2%	9	6	66.7%	18	8	44.4%	4	3	75.0%	1	8	0.0	+9	1	22	53.1%
11/10	MEM	W 127-121	37	26	7	1	2	2	3	9	4	44.4%	4	4	100.0%	13	8	61.5%	6	6	100.0%	0	7	0.3	-1	3	31	83.1%
11/8	IND	L 134-118	35	24	9	0	1	1	1	5	3	60.0%	11	5	45.5%	16	8	50.0%	6	5	83.3%	5	4	0.0	-12	1	28	64.4%
11/6	CHI	L 130-113	34	29	5	3	1	0	1	12	5	41.7%	3	3	100.0%	15	8	53.3%	8	8	100.0%	1	4	3.0	-12	2	33	78.3%
11/4	MIN	L 123-95	34	22	8	1	1	0	2	11	4	36.4%	9	3	33.3%	20	7	35.0%	5	4	80.0%	4	4	0.5	-16	4	21	49.5%
11/2	ORL	L 115-113	33	22	7	1	0	2	3	10	4	40.0%	7	5	71.4%	17	9	52.9%	2	0	0.0%	1	6	0.3	+2	4	20	61.5%
11/1	MEM	W 133-109	27	19	11	1	0	1	0	6	4	66.7%	5	2	40.0%	11	6	54.5%	3	3	100.0%	1	10	0.0	+10	5	24	77.1%
10/30	DEN	L 110-102	37	27	14	5	1	0	2	13	5	38.5%	11	5	45.5%	24	10	41.7%	2	2	100.0%	5	9	2.5	+3	2	29	54.3%
10/28	PHX	L 126-104	28	19	3	0	2	1	1	7	5	71.4%	6	2	33.3%	13	7	53.8%	0	0	0.0%	0	3	0.0	-21	1	18	73.1%
10/27	LAC	W 120-118	34	35	12	3	0	0	3	13	5	38.5%	10	7	70.0%	23	12	52.2%	6	6	100.0%	5	7	1.0	+11	2	40	68.3%
10/25	SAC	L 130-114	31	19	10	1	0	2	1	6	2	33.3%	9	4	44.4%	15	6	40.0%	6	5	83.3%	2	8	1.0	-7	1	26	53.9%
Regular Season Totals			33.1	23.2	8.2	2.0	0.5	0.9	1.4	8.0	3.2	39.9%	8.2	4.6	55.9%	16.2	7.8	48.0%	5.0	4.5	89.9%	2.2	5.9	1.4	+21	1.8	28.9	63.1%

Lauri Markkanen

#23 PF

Status

Previous game (vs. SAS 3/27)

Latest Lauri Markkanen news

Officially signs extension

2023-24 Season Stats

Lauri Markkanen Career Stats

Career Averages

Lauri Markkanen Season Stats

2024-25

2023-24

Previous Game (vs. SAS 3/27)

2023-24 Stats

2023-24 Rebounding

2023-24 Defensive

2023-24 Shooting

2023-24 Advanced

Lauri Markkanen Game Log

2024-25

2023-24

Lauri Markkanen Player Profile

Career History

Lauri Markkanen Fantasy Projections

It's the offseason! 😎

Lauri Markkanen Latest News

Officially signs extension

Will sign extension with Utah

Out for FIBA Qualifying Tournament

Re-evaluated in two weeks

Will not play versus Rockets

Questionable for Friday

Massive workload in loss

Cleared to play vs. San Antonio

Questionable for Wednesday

Lauri Markkanen

#23 PF

Unlock the latest Utah Jazz news — direct to your inbox.

Status

Previous game (vs. SAS 3/27)

Latest Lauri Markkanen news Subscribe

2023-24 Season Stats

Latest Lauri Markkanen news